BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14556963)

  • 1. Protective effect of bradykinin antagonist Hoe-140 during in vivo myocardial ischemic-reperfusion injury in the cat.
    Kumari R; Maulik M; Manchanda SC; Maulik SK
    Regul Pept; 2003 Oct; 115(3):211-8. PubMed ID: 14556963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pre- and posttreatment of losartan in feline model of myocardial ischemic-reperfusion injury.
    Kumari R; Manchanda SC; Maulik SK
    Methods Find Exp Clin Pharmacol; 2004; 26(1):39-45. PubMed ID: 14988740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril and its time of administration in myocardial ischaemic-reperfusion injury.
    Maulik SK; Kumari R; Maulik M; Manchanda SC; Gupta SK
    Pharmacol Res; 2001 Aug; 44(2):123-8. PubMed ID: 11516262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.
    Gupta SK; Saxena A; Singh U; Arya DS
    Mol Cell Biochem; 2005 Jul; 275(1-2):67-74. PubMed ID: 16335785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Development of Novel 1,3,5-Triazine-Procaine Derivatives as Protective Agent against Myocardial Ischemia/Reperfusion Injury via Inhibitor of Nuclear Factor-κB.
    Qiang Z; Yu W; Yu Y
    Pharmacology; 2019; 104(3-4):126-138. PubMed ID: 31212291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors.
    Vegh A; Papp JG; Parratt J
    Br J Pharmacol; 1994 Dec; 113(4):1167-72. PubMed ID: 7534181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury.
    Karthikeyan K; Bai BR; Gauthaman K; Sathish KS; Devaraj SN
    Life Sci; 2003 Oct; 73(21):2727-39. PubMed ID: 13679240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotection by Inula racemosa Hook in experimental model of myocardial ischemic reperfusion injury.
    Ojha S; Nandave M; Kumaria S; Arya DS
    Indian J Exp Biol; 2010 Sep; 48(9):918-24. PubMed ID: 21506500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary palm olein oil on oxidative stress associated with ischemic-reperfusion injury in isolated rat heart.
    Narang D; Sood S; Thomas MK; Dinda AK; Maulik SK
    BMC Pharmacol; 2004 Nov; 4():29. PubMed ID: 15535879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preischemic bradykinin and ischaemic preconditioning in functional recovery of the globally ischaemic rat heart.
    Starkopf J; Bugge E; Ytrehus K
    Cardiovasc Res; 1997 Jan; 33(1):63-70. PubMed ID: 9059529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bradykinin mediates myocardial ischaemic preconditioning against free radical injury in guinea-pig isolated heart.
    Jin ZQ; Chen X
    Clin Exp Pharmacol Physiol; 1998 Nov; 25(11):932-5. PubMed ID: 9807666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of bradykinin in myocardial preconditioning.
    Wall TM; Sheehy R; Hartman JC
    J Pharmacol Exp Ther; 1994 Aug; 270(2):681-9. PubMed ID: 8071859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats.
    Rajak S; Banerjee SK; Sood S; Dinda AK; Gupta YK; Gupta SK; Maulik SK
    Phytother Res; 2004 Jan; 18(1):54-60. PubMed ID: 14750202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism related to bradykinin and nitric oxide.
    Gourine AV; Pernow J; Poputnikov DM; Sjöquist PO
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):564-70. PubMed ID: 12352318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhiza glabra protects from myocardial ischemia-reperfusion injury by improving hemodynamic, biochemical, histopathological and ventricular function.
    Ojha S; Golechha M; Kumari S; Bhatia J; Arya DS
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):219-27. PubMed ID: 21975080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
    Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cardiac ATP-sensitive K+ channels induced by angiotensin II type 1 receptor antagonist on metabolism, contraction and relaxation in ischemia-reperfused rabbit heart.
    Kawabata H; Ryomoto T; Ishikawa K
    Jpn Circ J; 2001 May; 65(5):451-6. PubMed ID: 11348052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment.
    Gupta SK; Mohanty I; Talwar KK; Dinda A; Joshi S; Bansal P; Saxena A; Arya DS
    Mol Cell Biochem; 2004 May; 260(1-2):39-47. PubMed ID: 15228084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation.
    Giannella E; Mochmann HC; Levi R
    Circ Res; 1997 Sep; 81(3):415-22. PubMed ID: 9285644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of any additional benefit in combining aspirin with iloprost in a canine model of myocardial reperfusion injury.
    Maulik M; Seth SD; Manchanda SC; Maulik SK
    Prostaglandins; 1997 May; 53(5):291-303. PubMed ID: 9247970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.